Afatinib dimaleate is a potent, irreversible inhibitor of the ErbB family of tyrosine kinases, specifically targeting EGFR and HER2 receptors to treat non-small cell lung cancer and other malignancies.… Read more
Afatinib dimaleate is a potent, irreversible inhibitor of the ErbB family of tyrosine kinases, specifically targeting EGFR and HER2 receptors to treat non-small cell lung cancer and other malignancies. By blocking these signaling pathways, the drug effectively hinders tumor cell growth and proliferation in patients harboring specific genetic mutations. This category features a comprehensive range of high-quality afatinib dimaleate reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These critical research materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and routine quality control. Utilizing these characterized compounds ensures precision in analytical testing and stability monitoring, supporting the accurate detection and quantification of related substances throughout the drug development lifecycle.